DK0929566T3 - Fremgangsmåde til R-epimerberigelse af 16,17-acetal-derivater af 21-acyloxy-pregan-1,4-dien-11beta,16alfa,17alfa-triol-3,20-dion-derivater - Google Patents

Fremgangsmåde til R-epimerberigelse af 16,17-acetal-derivater af 21-acyloxy-pregan-1,4-dien-11beta,16alfa,17alfa-triol-3,20-dion-derivater

Info

Publication number
DK0929566T3
DK0929566T3 DK97942897T DK97942897T DK0929566T3 DK 0929566 T3 DK0929566 T3 DK 0929566T3 DK 97942897 T DK97942897 T DK 97942897T DK 97942897 T DK97942897 T DK 97942897T DK 0929566 T3 DK0929566 T3 DK 0929566T3
Authority
DK
Denmark
Prior art keywords
derivatives
16alpha
11beta
17alpha
triol
Prior art date
Application number
DK97942897T
Other languages
Danish (da)
English (en)
Inventor
Hermann Amschler
Dieter Flockerzi
Beate Schmidt
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7804358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0929566(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK0929566T3 publication Critical patent/DK0929566T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97942897T 1996-09-03 1997-08-29 Fremgangsmåde til R-epimerberigelse af 16,17-acetal-derivater af 21-acyloxy-pregan-1,4-dien-11beta,16alfa,17alfa-triol-3,20-dion-derivater DK0929566T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19635498A DE19635498A1 (de) 1996-09-03 1996-09-03 Verfahren zur Epimerenanreicherung
PCT/EP1997/004716 WO1998009982A1 (en) 1996-09-03 1997-08-29 Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione derivatives

Publications (1)

Publication Number Publication Date
DK0929566T3 true DK0929566T3 (da) 2003-04-07

Family

ID=7804358

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97942897T DK0929566T3 (da) 1996-09-03 1997-08-29 Fremgangsmåde til R-epimerberigelse af 16,17-acetal-derivater af 21-acyloxy-pregan-1,4-dien-11beta,16alfa,17alfa-triol-3,20-dion-derivater

Country Status (18)

Country Link
US (1) US6787533B1 (cs)
EP (1) EP0929566B1 (cs)
JP (1) JP3807509B2 (cs)
AT (1) ATE229539T1 (cs)
AU (1) AU736840B2 (cs)
CA (1) CA2264863C (cs)
CL (1) CL2004001297A1 (cs)
CY (2) CY2454B1 (cs)
CZ (1) CZ298789B6 (cs)
DE (2) DE19635498A1 (cs)
DK (1) DK0929566T3 (cs)
EE (1) EE03927B1 (cs)
ES (1) ES2188984T3 (cs)
HU (1) HU228766B1 (cs)
IL (1) IL128535A (cs)
PL (1) PL186063B1 (cs)
PT (1) PT929566E (cs)
WO (1) WO1998009982A1 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE10055820C1 (de) * 2000-11-10 2002-07-25 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung eines Glucocorticoids
DE60142920D1 (de) 2000-11-10 2010-10-07 Nycomed Gmbh Verfahren zur herstellung von 16,17-ä(cyclohexylmethylen)bis(oxy)ü -11,21-dihydroxy-pregna-1,4-dien-3,20-dion oder ihre 21-isobutyrat durch transketalisation
US20040235811A1 (en) 2002-10-08 2004-11-25 Sepracor Inc. Fatty acid modified forms of glucocorticoids
ES2312844T3 (es) 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
WO2005025578A1 (en) 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CN100345864C (zh) * 2004-10-29 2007-10-31 天津药业研究院有限公司 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
WO2007056181A2 (en) * 2005-11-02 2007-05-18 Sicor, Inc. Process for the preparation of ciclesonide
EP1904514A2 (en) * 2006-02-08 2008-04-02 Sicor, Inc. Crystalline forms of ciclesonide
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
EP2064227A2 (en) * 2006-09-19 2009-06-03 Cipla Ltd. Processes for the preparation of ciclesonide and its crystal form
JP2011513469A (ja) * 2008-03-13 2011-04-28 ファルマビオス ソシエタ ペル アチオニ プレグナン誘導体の製造法
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
US20100120737A1 (en) * 2008-11-10 2010-05-13 Martin Feth Amorphous ciclesonide
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
RS62040B1 (sr) 2016-06-02 2021-07-30 Abbvie Inc Agonist receptora glukokortikoida i njegovi imunokonjugati
EP3658192B1 (en) 2017-12-01 2021-04-28 AbbVie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
CN109293730A (zh) * 2018-10-23 2019-02-01 山东泰华生物科技股份有限公司 一种环索奈德的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
US3992534A (en) * 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
SE378110B (cs) * 1972-05-19 1975-08-18 Bofors Ab
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8604059D0 (sv) * 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5482935A (en) 1993-01-05 1996-01-09 American Home Product Corporation Anti-atherosclerotic use of 17 alpha-dihydroequilin
CZ287877B6 (cs) * 1993-04-02 2001-03-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Prednisolonové deriváty a farmaceutické prostředky s jejich obsahem
WO1995024416A1 (de) 1994-03-09 1995-09-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue silylverbindungen und ihre verwendung

Also Published As

Publication number Publication date
PL331699A1 (en) 1999-08-02
AU736840B2 (en) 2001-08-02
ATE229539T1 (de) 2002-12-15
DE69717836T2 (de) 2003-09-18
US6787533B1 (en) 2004-09-07
EE03927B1 (et) 2002-12-16
DE19635498A1 (de) 1998-03-26
JP3807509B2 (ja) 2006-08-09
JP2000517330A (ja) 2000-12-26
CZ298789B6 (cs) 2008-01-30
EP0929566A1 (en) 1999-07-21
EP0929566B1 (en) 2002-12-11
ES2188984T3 (es) 2003-07-01
EE9900079A (et) 1999-10-15
CY2009010I1 (el) 2010-07-28
CY2009010I2 (el) 2010-07-28
CZ72799A3 (cs) 1999-09-15
CY2454B1 (en) 2005-06-03
CA2264863C (en) 2007-07-31
PL186063B1 (pl) 2003-09-30
HUP9904127A2 (hu) 2000-04-28
WO1998009982A1 (en) 1998-03-12
PT929566E (pt) 2003-04-30
CL2004001297A1 (es) 2005-04-15
IL128535A0 (en) 2000-01-31
IL128535A (en) 2003-07-06
AU4456797A (en) 1998-03-26
HUP9904127A3 (en) 2001-02-28
DE69717836D1 (de) 2003-01-23
CA2264863A1 (en) 1998-03-12
HU228766B1 (hu) 2013-05-28

Similar Documents

Publication Publication Date Title
EE9900079A (et) Meetod 21-atsüüloksüpregna-1,4-dieen-11ß,16a,17a-triool-3,20-diooni derivaatide 16,17-atsetaalderivaatide R-epimeerseks rikastamiseks
DK243085A (da) Fremgangsmaade til fremstilling af 16,17-acetaler af pregnanderivaterog forbindelser fremstillet deraf
AU649472B2 (en) New pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters, process for their preparation, compositions and method for the treatment of inflammatory conditions
DK0674641T3 (da) Pyrrolopyrimidiner som CRF-antagonister
CA2165203A1 (fr) Concentre d'immunoglobulines g a usage therapeutique et procede de production dudit concentre
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
DK189484A (da) Steroidforbindelser af 20-spiroxanraekken og analoge deraf med aaben e-ring samt deres fremstilling og anvendelse
FI963450A0 (fi) Morfoliinitakykiniinireseptoriantagonistien lääke-esiastetta
DK0751129T3 (da) Substituerede dihydrodibenz/b,f/azepiner, fremgangsmåde til fremstilling deraf, deres anvendelse i behandlingen af nogle li
DK240890D0 (da) 9-alfa-hydroxy-17-methylensteroider, fremgangsmaade til fremstilling deraf og anvendelse af saadanne ved fremstillingen af corticosteroider
DK0923599T3 (da) Fremgangsmåde til fremstilling af 17-estere af 9alfa, 21-dihalogenpregnan-11beta, 17alfa-diol-20-oner
DK0770077T3 (da) Fremgangsmåde til fremstilling af 2-(1-azabicyclo[2.2.2]oct-3-yl)-2,4,5,6-tetrahydro-1h-benz[de]isoquinolin-1-on og mellemprodukter
HU9201190D0 (en) Method for producing new pregna-1,4-diene-3,20-dione derivatives
ATE478888T1 (de) Verfahren zur herstellung von 16,17- ä(cyclohexylmethylen)bis(oxy)ü -11,21-dihydroxy- pregna-1,4-dien-3,20-dion oder ihre 21-isobutyrat durch transketalisation
DK0935598T3 (da) 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet
DK0840724T3 (da) Fremgangsmåde til fremstilling af enantiomerisk ren azetidin-2-caboxylsyre
DK0608495T3 (da) Androstanderivater substitueret med en kvaternær ammoniumgruppe i 16-stillingen, farmaceutiske præparater indeholdende disse derivater og fremgangsmåde til deres fremstilling.
DK0520879T3 (da) 16-methylsubstituerede derivater af pregna-1,4-dien-3,20-dion, deres fremstilling, deres anvendelse til fremstilling af 16-methylensteroider og hidtil ukendte mellemprodukter
DK0627431T3 (da) Fremgangsmåde til fremstilling af krystallinsk loracarbef-monohydrat
DK364088A (da) Fremgangsmaade til fremstilling af flade emner, saasom luvforsynede maatter
DK161255C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive 18-substituerede pregn-4-en-3,20-dioner
DK0787729T3 (da) Fremgangsmåde til fremstilling af imidazodiazepinderivater
SI0929566T1 (en) Process for r-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione derivatives
DK0621264T3 (da) Fremgangsmåde til fremstilling af arylbenzylethere
DK146690C (da) Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion